Soleno Therapeutics(SLNO.US)

Last Updated 19:00:00 ET
longbridge loading

Neurocrine Unveils New INGREZZA Findings In Mild Tardive Dyskinesia At APA 2026; Closes Soleno Deal

nasdaq·
US
NBIX
-1.81%
US
SLNO
0.00%
US
IXJ
+0.79%
nasdaq·
US
NBIX
-1.81%
US
SLNO
0.00%
US
IXJ
+0.79%

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics | NBIX Stock News

StockTitan·
US
NBIX
-1.81%
US
FBT
+0.54%
US
ARKG
+0.04%
StockTitan·
US
NBIX
-1.81%
US
FBT
+0.54%
US
ARKG
+0.04%

13:32 ETSLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman

prnewswire·
US
SLNO
0.00%
US
LABD
+2.41%
US
BBH
+0.68%
prnewswire·
US
SLNO
0.00%
US
LABD
+2.41%
US
BBH
+0.68%

17:57 ETAre SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

prnewswire·
US
SLNO
0.00%
US
KORE
-0.11%
US
SEM
+0.18%
prnewswire·
US
SLNO
0.00%
US
KORE
-0.11%
US
SEM
+0.18%

Neurocrine Biosciences Q1 Adjusted Earnings, Revenue Rise

fidelity·
US
NBIX
-1.81%
fidelity·
US
NBIX
-1.81%

10:11 ETSLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

prnewswire·
US
SLNO
0.00%
US
IBB
+0.10%
US
LABU
-2.35%
prnewswire·
US
SLNO
0.00%
US
IBB
+0.10%
US
LABU
-2.35%
© 2026 Longbridge｜Disclaimer